Ruiqin Tu

416 total citations
23 papers, 320 citations indexed

About

Ruiqin Tu is a scholar working on Molecular Biology, Cancer Research and Obstetrics and Gynecology. According to data from OpenAlex, Ruiqin Tu has authored 23 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Obstetrics and Gynecology. Recurrent topics in Ruiqin Tu's work include Uterine Myomas and Treatments (4 papers), Healthcare cost, quality, practices (3 papers) and MicroRNA in disease regulation (3 papers). Ruiqin Tu is often cited by papers focused on Uterine Myomas and Treatments (4 papers), Healthcare cost, quality, practices (3 papers) and MicroRNA in disease regulation (3 papers). Ruiqin Tu collaborates with scholars based in China, United States and United Kingdom. Ruiqin Tu's co-authors include Lin Wang, Xizhong Shen, Ai‐Min Ren, Yanjie Chen, Hong-Fei Wu, Miaojun Zhu, Ruoying Tan, Yayun Wang, Lin Wang and Kai Xu and has published in prestigious journals such as PLoS ONE, Life Sciences and American Journal of Neuroradiology.

In The Last Decade

Ruiqin Tu

20 papers receiving 317 citations

Peers

Ruiqin Tu

ONCOL

Xiaoke Wu China

Shunyu Hou China

Séverine Iborra Germany

Subbiah Shanmugam India

Jennifer X. Ji Canada

Justin Harold United States

Nicoletta Provinciali Italy

Xuan Pei China

J. de Santiago Spain

Alejandra Wernicke Argentina

Xiaoke Wu China

Ruiqin Tu

291 ×1.5

213 ×1.5

24 ×0.5

42 ×1.0

ONCOL

17 ×0.6

Citations per year, relative to Ruiqin Tu Ruiqin Tu (= 1×) peers Xiaoke Wu

Countries citing papers authored by Ruiqin Tu

Since Specialization

Citations

This map shows the geographic impact of Ruiqin Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruiqin Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruiqin Tu more than expected).

Fields of papers citing papers by Ruiqin Tu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruiqin Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruiqin Tu. The network helps show where Ruiqin Tu may publish in the future.

Co-authorship network of co-authors of Ruiqin Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Ruiqin Tu. A scholar is included among the top collaborators of Ruiqin Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruiqin Tu. Ruiqin Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhong, Xiaolin, et al.. (2025). Dynamics of Conventional Metabolic Indices in Relation to Endometriosis Severity: A Retrospective Analysis. International Journal of General Medicine. Volume 18. 5183–5193.

Zhang, Fei, et al.. (2022). Immune Subtypes Characterization Identifies Clinical Prognosis, Tumor Microenvironment Infiltration, and Immune Response in Ovarian Cancer. Frontiers in Molecular Biosciences. 9. 801156–801156. 2 indexed citations

Shi, Peipei, Hua Li, Ai‐Min Ren, et al.. (2022). Management and prognosis comparison between incidental and nonincidental intravenous leiomyomatosis: a retrospective single-center real-life experience. Annals of Translational Medicine. 10(9). 503–503. 7 indexed citations

Li, Hua, Jing Xu, Yong Zhang, et al.. (2020). Surgical treatment strategies for extra-pelvic intravenous leiomyomatosis. Orphanet Journal of Rare Diseases. 15(1). 153–153. 17 indexed citations

Tu, Ruiqin, et al.. (2019). Chimeric Antigen Receptor T-Cell Therapy: What the Neuroradiologist Needs to Know. American Journal of Neuroradiology. 40(5). 766–768. 8 indexed citations

Hirsch, Joshua A, et al.. (2018). Comparison of Advanced Imaging Resources, Radiology Workforce, and Payment Methodologies between the United States and Canada. American Journal of Neuroradiology. 39(10). 1785–1790. 3 indexed citations

Tu, Ruiqin, et al.. (2017). Health Care Economics: A Study Guide for Neuroradiology Fellows, Part 2. American Journal of Neuroradiology. 39(1). 10–17. 5 indexed citations

Tu, Ruiqin, et al.. (2017). Health Care Economics: A Study Guide for Neuroradiology Fellows, Part 1. American Journal of Neuroradiology. 39(1). 2–9. 3 indexed citations

Tang, Qin, Ziqing Li, Zitong Zhao, et al.. (2017). Prostaglandin E 2 regulates renal function in C57/BL6 mouse with 5/6 nephrectomy. Life Sciences. 174. 68–76. 9 indexed citations

10.

Tu, Ruiqin, et al.. (2016). Genetics of Von Hippel-Lindau Disease. American Journal of Neuroradiology. 38(3). 469–470. 7 indexed citations

11.

Tu, Ruiqin, et al.. (2016). Genetics of Frontotemporal Dementia. American Journal of Neuroradiology. 38(1). 10–11. 7 indexed citations

12.

Chokshi, Falgun H., Ruiqin Tu, Gregory N. Nicola, & Joshua A Hirsch. (2016). Myelography CPT Coding Updates: Effects of 4 New Codes and Unintended Consequences. American Journal of Neuroradiology. 37(6). 997–999. 6 indexed citations

13.

Sun, Huizhen, Yán Li, Ruiqin Tu, et al.. (2016). Expression Profiles of Endometrial Carcinoma by Integrative Analysis of TCGA Data. Gynecologic and Obstetric Investigation. 82(1). 30–38. 9 indexed citations

14.

Ben-David, Eliel & Ruiqin Tu. (2014). Genetics of Parkinson Disease. American Journal of Neuroradiology. 36(3). 445–447. 4 indexed citations

15.

Wang, Lin, Miaojun Zhu, Ai‐Min Ren, et al.. (2014). A Ten-MicroRNA Signature Identified from a Genome-Wide MicroRNA Expression Profiling in Human Epithelial Ovarian Cancer. PLoS ONE. 9(5). e96472–e96472. 100 indexed citations

16.

Wang, Lin, Yanjie Chen, Jun Hou, et al.. (2014). Expression and clinical significance of BIRC6 in human epithelial ovarian cancer. Tumor Biology. 35(5). 4891–4896. 20 indexed citations

17.

Wang, Lin, Yanjie Chen, Kai Xu, et al.. (2014). High expression of UCH37 is significantly associated with poor prognosis in human epithelial ovarian cancer. Tumor Biology. 35(11). 11427–11433. 42 indexed citations

18.

Wang, Lin, Yanjie Chen, Kai Xu, et al.. (2014). Circulating microRNAs as a Fingerprint for Endometrial Endometrioid Adenocarcinoma. PLoS ONE. 9(10). e110767–e110767. 33 indexed citations

19.

Zhang, Yong, et al.. (2013). Multimodality treatment of two cases of intracardiac leiomyomatosis with enormous mass in the abdominopelvic cavity. Expert Review of Anticancer Therapy. 13(2). 137–141. 3 indexed citations

20.

Zhang, Tingting, et al.. (2012). Gestrinone inhibits growth of human uterine leiomyoma may relate to activity regulation of ERα, Src and P38 MAPK. Biomedicine & Pharmacotherapy. 66(8). 569–577. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact